Cowen Starts MacroGenics (MGNX) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts MGNX Hot Sheet
Price: $2.25 -38.02%
Rating Summary:
13 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Rating Summary:
13 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Join SI Premium – FREE
Cowen initiated coverage on MacroGenics (NASDAQ: MGNX) with an Outperform rating.
For an analyst ratings summary and ratings history on MacroGenics click here. For more ratings news on MacroGenics click here.
Shares of MacroGenics closed at $29.97 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MacroGenics reports Phase 1 data for MGC026 cancer drug at ESMO
- Procter & Gamble (PG) PT Raised to $166 at TD Cowen
- Western Digital Corp. (WDC) PT Lowered to $430 at TD Cowen
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
